Journal of Contemporary Psychotherapy

, Volume 47, Issue 4, pp 223–232 | Cite as

Metacognitive Interpersonal Therapy Improves Adherence to Antiretroviral Therapies in a Man with a Severe Personality Disorder: A Case Report

  • Sonia A. Sofia
  • Paul H. Lysaker
  • Giancarlo Dimaggio
Original Paper

Abstract

Treatment adherence by patients with HIV ensures they gain the full benefit of antiretroviral medications and extend their lives. One problem which may contribute to poor adherence is deficits in metacognition or the capacity to make sense of mental states. In particular, persons who struggle to notice and think about their thoughts and feelings may be less able to direct their own recovery by taking advantage of effective treatments. This raises the possibility that treatments which lead to improved metacognitive function may enhance treatment adherence. We describe the case of a man in an advanced stage of AIDS with Kaposi’s sarcoma. The patient was treated with Metacognitive Interpersonal Therapy combined with psychoeducation about pharmacological treatment for HIV. Primary medical outcomes were suppression of viral load, increase of CD4 count and control of AIDS related conditions such as Kaposi’s sarcoma. The primary psychological outcome was reduction of personality disorders criteria. The patient was able to understand what led him to discontinue medication and then later regain full adherence. He achieved suppression of viral load and restore of CD4 count. As regard severity of personality disorder, he achieved reliable change. Interventions such as Metacognitive Interpersonal Therapy may assist patients with HIV to gain the metacognitive capacities to make sense of their medical and psychological challenges and adhere to antiretroviral therapies leading to enhanced levels of health. Future studies are needed to explore these findings in larger controlled studies.

Keywords

Metacognitive interpersonal therapy Therapy adherence HIV Personality disorders 

Notes

Author Contributions

All authors have made substantial contributions to conception and design of the study. All authors have been involved in drafting the manuscript and revising it critically for important intellectual content. All authors read and approved the final manuscript. S.S. has carried out patient psychotherapy. G.D. has carried out the supervision of the psychotherapy.

Compliance with Ethical Standards

Conflict of interests

The authors declare that they have no competing interests.

Informed Consent

Written informed consent was obtained from the patient for publication of this case report. A copy of the written consent is available for review by the Editor of this journal.

References

  1. Abbass, A. A. (2003). The cost-effectiveness of short-term dynamic psychotherapy. Expert Review of Pharmacoeconomics & Outcomes Research, 3, 535–539.CrossRefGoogle Scholar
  2. Abel, E., & Painter, L. (2003). Factors that influence adherence HIV medications: Perceptions of women and health care providers. The Journal of the Association of Nurses in AIDS Care, 14(4), 61–69.CrossRefPubMedGoogle Scholar
  3. Altice, F. L., & Friedland, G. H. (1998). The era of adherence to HIV Therapy. Annals of Internal Medicine, 129, 503–505.CrossRefPubMedGoogle Scholar
  4. Bagby, R. M., Parker, J. D. A., & Taylor, G. J. (1994). The twenty item Toronto alexithymia scale I. Item selection and cross validation of the factor structure Journal of Psychosomatic Research, 38, 23–32.PubMedGoogle Scholar
  5. Baldwin, M. W. (1992). Relational schemas and the processing of social information. Psychological Bulletin, 112, 461–484.CrossRefGoogle Scholar
  6. Bezabhe, W. M., Chalmers, L., Bereznicki, L. R., Peterson, G. M. (2016). Adherence to antiretroviral therapy and virologic failure: A meta-analysis. Medicine, 95(15), e3361. doi: 10.1097/MD.0000000000003361.CrossRefPubMedPubMedCentralGoogle Scholar
  7. Carcione, A., Semerari, A., Nicolò, G., Pedone, R., Popolo, R., Conti, L., Fiore, D., Procacci, M., & Dimaggio, G. (2011). Metacognitive mastery dysfunctions in personality disorder psychotherapy. Psychiatry Research, 190, 60–71.CrossRefPubMedGoogle Scholar
  8. Chesney, M. A. (1999) The challenge of adherence. Beta. 12, 10–13. [PubMed].PubMedGoogle Scholar
  9. Chesney, M. A. (2000). Factors affecting adherence to antiretroviral therapy. Clinical Infectious Disease, 30(2), S171–S176.CrossRefGoogle Scholar
  10. Dimaggio, G., Semerari, A., Carcione, A., Nicolò, G., & Procacci, M. (2007). Psychotherapy of personality disorders: Metacognition, states of mind and interpersonal cycles. London: Routledge.Google Scholar
  11. Dimaggio, G., Carcione, A., Nicolò, G., Lysaker, P. H., d’Angerio, S., Conti, M. L., Fiore, D., Pedone, R., Procacci, M., Popolo, R., & Semerari, A. (2013). Differences between axes depend on where you set the bar. Associations among symptoms, interpersonal relationship and alexithymia with number of personality disorder criteria. Journal of Personality Disorders, 27, 371–382. doi: 10.1521/pedi_2012_26_043.CrossRefPubMedGoogle Scholar
  12. Dimaggio, G., Valeri, S., Ottavi, P., Popolo, R., Salvatore, G., & Montano, A. (2014). Adopting metacognitive interpersonal therapy to treat narcissistic personality disorder with severe somatization. Journal of Contemporary Psychotherapy, 44, 85–95. doi: 10.1007/s10879-013-9254-8.CrossRefGoogle Scholar
  13. Dimaggio, G., & Lysaker, P. H. (2015). Metacognition and mentalizing in the psychotherapy of patients with psychosis and personality disorders. Journal of Clinical Psychology: In-Session, 71, 117–124. doi: 10.1002/jclp.22147.CrossRefPubMedGoogle Scholar
  14. Dimaggio, G., Montano, A., Popolo, R., & Salvatore, G. (2015a). Metacognitive interpersonal therapy for personality disorders: A treatment manual. London: Routledge.Google Scholar
  15. Dimaggio, G., D’Urzo, M., Pasinetti, M., Salvatore, G., Lysaker, P. H., Catania, D., & Popolo, R. (2015b). Metacognitive interpersonal therapy for avoidant personality disorders and substance abuse. Journal of Clinical Psychology: In-Session, 71, 157–166. doi: 10.1002/jclp.22151.CrossRefPubMedGoogle Scholar
  16. Dimaggio, G., Salvatore, G., Lysaker, P. H., Ottavi, P., & Popolo, R. (2015c). Behavioral activation revised as a common mechanism of change for personality disorders psychotherapy. Journal of Psychotherapy Integration, 25, 30–38. doi: 10.1037/a0038769.CrossRefGoogle Scholar
  17. Dimaggio, G., Conti, C., Lysaker, P. H., Popolo, R., Salvatore, G., & Sofia. S. A. (2016). Reauthoring one’s own life in the face of being HIV+. Promoting healthier narratives with Metacognitive Interpersonal Therapy. Journal of Constructivist Psychology, 1–16Google Scholar
  18. First, M. B., Gibbon, M., Spitzer, R. L, Williams, J. B. W., & Benjamin, L. S. (1997). Structured clinical interview for DSM-IV axis II personality disorders, (SCID-II). Washington, D.C.: American Psychiatric Press, Inc.Google Scholar
  19. Grierson, J., Bartos, M., De Visser, R., & McDonald, K. (2000). HIV futures II: the health and well being of people with HIV/AIDS in Australia. Monograph Series Number 17. The Australian Res. Centre in Sex, Health, and Society. Melbourne: La Trobe University.Google Scholar
  20. Holzemer, W. L., Corless, I. B., Nokes, K. M., Turner, J. G., Brown, M. A., Powell-Cope, G. M., Inouye, J., Henry, S. B., Nicholas, P. K., & Portillo, C. J. (1999). Predictors of self-reported adherence in persons living with HIV disease. AIDS Patient Care and STDs, 13(3), 185–197.CrossRefPubMedGoogle Scholar
  21. Jacobson, N. S., & Truax, P. (1991). Clinical significance: a statistical approach to defining meaningful change in psychotherapy-research. Journal of Consulting and Clinical Psychology, 59, 12–19.CrossRefPubMedGoogle Scholar
  22. Kleeberger, C. A., Buechner, J., Palella, F., Detels, R., Riddler, S., Godfrey, R., & Jacobson, L. P. (2004). Changes in adherene to highly active antiretroviral therapy medications in the multicenter AIDS cohort study. AIDS, 18(4), 683–688.CrossRefPubMedGoogle Scholar
  23. Langebeek, N., Gisolf, E. H., Reiss, P., Vervoort, S. C., Hafsteinsdóttir, T. B., Richter, C., Sprangers MAG, & Nieuwkerk, P. T. (2014). BMC Medicine, 12, 142. http://www.biomedcentral.com/1741-7015/12/142.
  24. Luborsky, L., & Crits-Christoph, P. (1998). Understanding transference: The core conflictual relationship theme method (2nd edn.). New York, NY: Basic Book.CrossRefGoogle Scholar
  25. Lysaker, P. H., & Dimaggio, G. (2014). Metacognitive capacities for reflection in schizophrenia: Implications for developing treatments. Schizophrenia Bulletin, 40, 487–491. doi: 10.1093/schbul/sbu038.CrossRefPubMedPubMedCentralGoogle Scholar
  26. Lysaker, P. H., Olesek, K., Buck, K., Leonhardt, B., Vohs, J., Dimaggio, G., Popolo, R., & Outcalt, J. (2014). Metacognitive mastery moderates the relationship of alexithymia with cluster C personality disorder traits in adults with substance use disorders. Addictive Behaviors, 39, 558–561.  10.1016/j.addbeh.2013.11.007.CrossRefPubMedGoogle Scholar
  27. Lysaker, P. H., Ringer, J. M., Buck, K. D., Grant, M., Olesek, K., Leudtke, B. L., Dimaggio, G., (2012). Metacognitive and social cognition deficits in patients with significant psychiatric and medical adversity a comparison between participants with schizophrenia and a sample of participants who are HIV-positive. The Journal of Nervous and Mental Disease, 200, 130–134.CrossRefPubMedGoogle Scholar
  28. McIntosh, R. C., Ironson, G., Antoni, M., Fletcher, M. A., & Schneiderman, N. (2016). Alexithymia, assertiveness and psychosocial functioning in HIV: Implications for medication adherence and disease severity. AIDS and Behavior, 20(2), 325–338. doi: 10.1007/s10461-015-1126-7.CrossRefPubMedGoogle Scholar
  29. Moran, G., Fonagy, P., Kurtz, A., Bolton, A., & Brook, C. (1991). A controlled study of the psychoanalytic treatment of brittle diabetes. Journal of the American Academy of Child & Adolescent Psychiatry, 30, 926–935.CrossRefGoogle Scholar
  30. Outcalt, J., Dimaggio, G., Popolo, R., Olesek, K. L., Buck, K., & Lysaker, P. H. (2016). Metacognition moderates the relationship of disturbances in attachment with severity of borderline personality disorder among persons in treatment for substance use disorders. Comprehensive Psychiatry, 64, 22–28.CrossRefPubMedGoogle Scholar
  31. Pence, B. W., Miller, W. C., Gaynes, B. N., & Eron, J. J. Jr. (2007). Psychiatric illness and virologic response in patients initiating highly active antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes, 44(2), 159–166.CrossRefPubMedGoogle Scholar
  32. Pratt R, Robinson N, Loveday HP, Pellowe CM, Franks PJ. (1998). Improvement in sexual drive and a falling viral load are associated with adherence to HAART therapy. Geneva: 12th World AIDS Conference.Google Scholar
  33. Safran, J. D., & Muran, J. C. (2000). Negotiating the therapeutic alliance. A relational treatment guide. New York, NY: Guilford.Google Scholar
  34. Semerari, A., Carcione, A., Dimaggio, G., Falcone, M., Nicolò, G., Procacci, M., & Alleva, G. (2003). How to evaluate metacognitive functioning in psychotherapy? The metacognition assessment scale and its applications. Clinical Psychology and Psychotherapy, 10, 238–261.CrossRefGoogle Scholar
  35. Semerari, A., Carcione, A., Dimaggio, G., Nicolò, G., & Procacci, M. (2007). Understanding minds, different functions and different disorders? The contribution of psychotherapeutic research. Psychotherapy Research, 17, 106–119.CrossRefGoogle Scholar
  36. Spielberger, C. D., Gorsuch, R. L., Lushene, R., Vagg, P. R., & Jacobs, G. A. (1983). Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press.Google Scholar
  37. Starace, F., Ammassari, A., Trotta, M. P., Murri, R., De Longis, P., Izzo, C., et al. (2002). Depression is a risk factor for suboptimal adherence to highly active antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes, 31(3), 136–139.CrossRefGoogle Scholar
  38. Tseng, A. (1998). Compliance issues in the treatment of HIV infection. American Journal of Health-System Pharmacy, 55(17), 1817–1824.PubMedGoogle Scholar
  39. Verheul, R., Bartak, A., & Widiger, T. (2007). Prevalence and construct validity of personality disorder not otherwise specified. Journal of Personality Disorders, 21, 359–370.CrossRefPubMedGoogle Scholar
  40. Westerfelt, A. (2004). A qualitative investigation of adherence issues for men who are HIV positive. Social Work, 49(2), 609–615.CrossRefGoogle Scholar
  41. Wilberg, T., Hummelen, B., Pedersen, G., & Karterud, S. (2008). A study of patients with personality disorder not otherwise specified. Comprehensive Psychiatry, 49, 460–468.CrossRefPubMedGoogle Scholar
  42. Williams, A., & Friedland, G. (1997). Adherence, compliance, and HAART. AIDS Clinical Care, 9(7), 51–53.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2017

Authors and Affiliations

  • Sonia A. Sofia
    • 1
  • Paul H. Lysaker
    • 2
    • 3
  • Giancarlo Dimaggio
    • 4
  1. 1.Department of Clinical and Molecular Biomedicine, Division of Infectious DiseasesUniversity of CataniaCataniaItaly
  2. 2.Richard L Roudebush VA Medical CenterIndianpolisUSA
  3. 3.Department of PsychiatryIndiana University School of MedicineIndianpolisUSA
  4. 4.Centro di Terapia Metacognitiva InterpersonaleRomeItaly

Personalised recommendations